As of mid-August 2026, the CDC reports 2,566 confirmed U.S. measles cases year-to-date—already exceeding the full-year 2025 total of 2,289 and marking the highest annual figure since 1991—with 94% outbreak-associated across 38 clusters and most occurring in unvaccinated or under-vaccinated individuals. Sustained transmission from 2025 outbreaks, combined with MMR coverage falling below the 95% herd-immunity threshold in multiple communities, drives continued spread, while imported cases from international travelers seed new chains. Weekly CDC surveillance updates and any Pan American Health Organization review of elimination status (lost risk heightened by consecutive high-case years) represent key upcoming data points that could shift market-implied odds on total 2026 volume or thresholds.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertMasernfälle in den USA im Jahr 2026?
Masernfälle in den USA im Jahr 2026?
$7,837,219 Vol.
$7,837,219 Vol.
31. Dez. 2026
↑4,5k
54%
↑3k
97%
↑3,5 Tsd.
95%
↑4k
79%
↑5k
35%
↑7,5k
12%
↑10k
6%
↑12,5k
5%
$7,837,219 Vol.
$7,837,219 Vol.
31. Dez. 2026
↑4,5k
$22 Vol.
54%
↑3k
$90,832 Vol.
97%
↑3,5 Tsd.
$13,859 Vol.
95%
↑4k
$224,361 Vol.
79%
↑5k
$231,079 Vol.
35%
↑7,5k
$185,225 Vol.
12%
↑10k
$6,516,157 Vol.
6%
↑12,5k
$349,917 Vol.
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, the CDC reports 2,566 confirmed U.S. measles cases year-to-date—already exceeding the full-year 2025 total of 2,289 and marking the highest annual figure since 1991—with 94% outbreak-associated across 38 clusters and most occurring in unvaccinated or under-vaccinated individuals. Sustained transmission from 2025 outbreaks, combined with MMR coverage falling below the 95% herd-immunity threshold in multiple communities, drives continued spread, while imported cases from international travelers seed new chains. Weekly CDC surveillance updates and any Pan American Health Organization review of elimination status (lost risk heightened by consecutive high-case years) represent key upcoming data points that could shift market-implied odds on total 2026 volume or thresholds.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Markt eröffnet: Feb 16, 2026, 11:51 AM ET
Volumen
$7,837,219Enddatum
31. Dez. 2026Markt eröffnet
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, the CDC reports 2,566 confirmed U.S. measles cases year-to-date—already exceeding the full-year 2025 total of 2,289 and marking the highest annual figure since 1991—with 94% outbreak-associated across 38 clusters and most occurring in unvaccinated or under-vaccinated individuals. Sustained transmission from 2025 outbreaks, combined with MMR coverage falling below the 95% herd-immunity threshold in multiple communities, drives continued spread, while imported cases from international travelers seed new chains. Weekly CDC surveillance updates and any Pan American Health Organization review of elimination status (lost risk heightened by consecutive high-case years) represent key upcoming data points that could shift market-implied odds on total 2026 volume or thresholds.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$7,837,219Enddatum
31. Dez. 2026Markt eröffnet
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...As of mid-August 2026, the CDC reports 2,566 confirmed U.S. measles cases year-to-date—already exceeding the full-year 2025 total of 2,289 and marking the highest annual figure since 1991—with 94% outbreak-associated across 38 clusters and most occurring in unvaccinated or under-vaccinated individuals. Sustained transmission from 2025 outbreaks, combined with MMR coverage falling below the 95% herd-immunity threshold in multiple communities, drives continued spread, while imported cases from international travelers seed new chains. Weekly CDC surveillance updates and any Pan American Health Organization review of elimination status (lost risk heightened by consecutive high-case years) represent key upcoming data points that could shift market-implied odds on total 2026 volume or thresholds.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen